Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer

por Yonemori, Masaya, Seki, Naohiko, Yoshino, Hirofumi, Matsushita, Ryosuke, Miyamoto, Kazutaka, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2016

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma

por Yoshino, Hirofumi, Yonemori, Masaya, Miyamoto, Kazutaka, Tatarano, Syuichi, Kofuji, Satoshi, Nohata, Nijiro, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2017

Significance of preoperative screening of deep vein thrombosis and its indications for patients undergoing urological surgery

por Tatarano, Shuichi, Enokida, Hideki, Yonemori, Masaya, Eura, Rumiko, Yoshino, Hirofumi, Nishimura, Hiroaki, Yamada, Yasutoshi, Nakagawa, Masayuki
Publicado 2021

Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): inhibition of bladder cancer cell aggressiveness

por Matsushita, Ryosuke, Yoshino, Hirofumi, Enokida, Hideki, Goto, Yusuke, Miyamoto, Kazutaka, Yonemori, Masaya, Inoguchi, Satoru, Nakagawa, Masayuki, Seki, Naohiko
Publicado 2016

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer

por OKATO, ATSUSHI, GOTO, YUSUKE, KUROZUMI, AKIRA, KATO, MAYUKO, KOJIMA, SATOKO, MATSUSHITA, RYOSUKE, YONEMORI, MASAYA, MIYAMOTO, KAZUTAKA, ICHIKAWA, TOMOHIKO, SEKI, NAOHIKO
Publicado 2016

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

por Sakaguchi, Takashi, Yoshino, Hirofumi, Yonemori, Masaya, Miyamoto, Kazutaka, Sugita, Satoshi, Matsushita, Ryosuke, Itesako, Toshihiko, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2017

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

por Sakaguchi, Takashi, Yoshino, Hirofumi, Yonemori, Masaya, Miyamoto, Kazutaka, Sugita, Satoshi, Matsushita, Ryosuke, Itesako, Toshihiko, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2018

Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation

por Yoshino, Hirofumi, Enokida, Hideki, Osako, Yoichi, Nohata, Nijiro, Yonemori, Masaya, Sugita, Satoshi, Kuroshima, Kazuki, Tsuruda, Masafumi, Tatarano, Shuichi, Nakagawa, Masayuki
Publicado 2020

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma

por Sakaguchi, Takashi, Yoshino, Hirofumi, Sugita, Satoshi, Miyamoto, Kazutaka, Yonemori, Masaya, Osako, Yoichi, Meguro-Horike, Makiko, Horike, Shin-Ichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2018

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

por Okamura, Shunsuke, Yoshino, Hirofumi, Kuroshima, Kazuki, Tsuruda, Masafumi, Osako, Yoichi, Sakaguchi, Takashi, Yonemori, Masaya, Yamada, Yasutoshi, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2021

microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1

por Tamai, Motoki, Tatarano, Shuichi, Okamura, Shunsuke, Fukumoto, Wataru, Kawakami, Issei, Osako, Yoichi, Sakaguchi, Takashi, Sugita, Satoshi, Yonemori, Masaya, Yamada, Yasutoshi, Nakagawa, Masayuki, Enokida, Hideki, Yoshino, Hirofumi
Publicado 2022

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectom...

por Miyake, Makito, Iida, Kota, Nishimura, Nobutaka, Inoue, Takashi, Matsumoto, Hiroaki, Matsuyama, Hideyasu, Fujiwara, Yuya, Komura, Kazumasa, Inamoto, Teruo, Azuma, Haruhito, Yasumoto, Hiroaki, Shiina, Hiroaki, Yonemori, Masaya, Enokida, Hideki, Nakagawa, Masayuki, Fukuhara, Hideo, Inoue, Keiji, Yoshida, Takashi, Kinoshita, Hidefumi, Matsuda, Tadashi, Fujii, Tomomi, Fujimoto, Kiyohide
Publicado 2022